Efficacy and Safety of Cinobufacin Combined with Chemotherapy for Advanced Breast Cancer: A Systematic Review and Meta-Analysis.

Published in: Evidence-based complementary and alternative medicine : eCAM (2020)

Cinobufacin combined with chemotherapy can improve the clinical efficacy of breast cancer patients, enhance the quality of life of the patients, reduce the value of tumor markers such as CA125, CA153, and CEA, and lower the occurrence of adverse reactions such as gastrointestinal reactions, liver and kidney damage, and hair loss.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
locally advanced
chronic kidney disease
risk assessment
oxidative stress
peritoneal dialysis
emergency department
squamous cell carcinoma
young adults
drug induced
adverse drug
electronic health record